日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PPARγ, a key modulator of metabolic reprogramming, stemness and chemoresistance associated with retrodifferentiation in human hepatocellular carcinomas

PPARγ是代谢重编程、干性和化疗耐药性的关键调节因子,与人类肝细胞癌的逆分化有关。

Yoann Daniel ,Claudine Rauch ,Lucille Moutaux ,Lise Desquilles ,Tifenn Le Charpentier ,Karim Fekir ,Luis Cano ,Daniel Catheline ,Servane Pierre ,Agnès Burel ,Camille Savary ,Catherine Ribault ,Claude Bendavid ,Bruno Clément ,Caroline Aninat ,Vincent Rioux ,Orlando Musso ,Bernard Fromenty ,Florian Cabillic # ,Anne Corlu #

Roadmap to DILI research in Europe. A proposal from COST action ProEuroDILINet

欧洲药物诱导肝病 (DILI) 研究路线图。COST 行动 ProEuroDILINEt 的提案

Lucena, M I; Villanueva-Paz, M; Alvarez-Alvarez, I; Aithal, G P; Björnsson, E S; Cakan-Akdogan, G; Cubero, F J; Esteves, F; Falcon-Perez, J M; Fromenty, B; Garcia-Ruiz, C; Grove, J I; Konu, O; Kranendonk, M; Kullak-Ublick, G A; Miranda, J P; Remesal-Doblado, A; Sancho-Bru, P; Nelson, L; Andrade, R J; Daly, A K; Fernandez-Checa, J C

A strategy to detect metabolic changes induced by exposure to chemicals from large sets of condition-specific metabolic models computed with enumeration techniques

一种利用枚举技术计算的大量特定条件代谢模型,来检测化学物质暴露引起的代谢变化的策略

Fresnais, Louison; Perin, Olivier; Riu, Anne; Grall, Romain; Ott, Alban; Fromenty, Bernard; Gallardo, Jean-Clément; Stingl, Maximilian; Frainay, Clément; Jourdan, Fabien; Poupin, Nathalie

Acetaminophen (APAP, Paracetamol) Interferes With the First Trimester Human Fetal Ovary Development in an Ex Vivo Model

乙酰氨基酚 (APAP,扑热息痛) 干扰体外模型中妊娠前三个月人类胎儿卵巢的发育

Laetitia L Lecante, Sabrina Leverrier-Penna, Thomas Gicquel, Frank Giton, Nathalie Costet, Christèle Desdoits-Lethimonier, Laurianne Lesné, Bernard Fromenty, Vincent Lavoué, Antoine D Rolland, Séverine Mazaud-Guittot

Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease

外源性物质诱发的代谢相关脂肪肝疾病加重

Massart, Julie; Begriche, Karima; Corlu, Anne; Fromenty, Bernard

Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity

HepaRG 细胞中不存在严重线粒体功能障碍的情况下的药物诱导性肝脂肪变性:基于多种机制的毒性证据

Julien Allard, Simon Bucher, Julie Massart, Pierre-Jean Ferron, Dounia Le Guillou, Roxane Loyant, Yoann Daniel, Youenn Launay, Nelly Buron, Karima Begriche, Annie Borgne-Sanchez, Bernard Fromenty

Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients

药物毒性研究的分子网络:羟氯喹治疗 COVID-19 患者案例

Pierre-Jean Ferron, Brendan Le Daré, Julie Bronsard, Clara Steichen, Elodie Babina, Romain Pelletier, Thierry Hauet, Isabelle Morel, Karin Tarte, Florian Reizine, Bruno Clément, Bernard Fromenty, Thomas Gicquel

The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds

GOLIATH项目:迈向代谢干扰化合物测试的国际统一方法

Legler, Juliette; Zalko, Daniel; Jourdan, Fabien; Jacobs, Miriam; Fromenty, Bernard; Balaguer, Patrick; Bourguet, William; Munic Kos, Vesna; Nadal, Angel; Beausoleil, Claire; Cristobal, Susana; Remy, Sylvie; Ermler, Sibylle; Margiotta-Casaluci, Luigi; Griffin, Julian L; Blumberg, Bruce; Chesné, Christophe; Hoffmann, Sebastian; Andersson, Patrik L; Kamstra, Jorke H

Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?

对于患有既往代谢功能障碍相关脂肪肝疾病的新冠肺炎患者,治疗是否存在药物性肝损伤的潜在风险?

Ferron, Pierre-Jean; Gicquel, Thomas; Mégarbane, Bruno; Clément, Bruno; Fromenty, Bernard

Retrodifferentiation of Human Tumor Hepatocytes to Stem Cells Leads to Metabolic Reprogramming and Chemoresistance

人类肿瘤肝细胞向干细胞的逆转分化导致代谢重编程和化学抗性

Karim Fekir, Hélène Dubois-Pot-Schneider, Romain Désert, Yoann Daniel, Denise Glaise, Claudine Rauch, Fabrice Morel, Bernard Fromenty, Orlando Musso, Florian Cabillic, Anne Corlu